Invasive Cervical Cancer
American Society of Clinical OncologyPublished: February 15, 2022
- Key Points
- Facility Specifications
- Diagnosis
- Treatment
- Tables
- Treatment Capacity
- Evaluation
- Recommendations for Stage IA, IB, and IIA Disease
- Combination of Three Risk Factors: CLS, Stromal Invasion, and Tumor Size by Treatment Regimen
- Recommendations for Stage IIB, III, IVA, and IVB and Recurrent Disease
Also Found In
You rely on Guideline Central for transparency
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.